Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in First-Episode Psychosis
NCT00916461Phase 2Completed
- Sponsor
- Stanley Medical Research Institute
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of minocycline in schizophrenia, schizoaffective disorder and psychotic disorder (2 arms), sponsored by Stanley Medical Research Institute. Primary endpoint: Positive and Negative Syndrome Scale at 12 months. Started May 2006; status: completed.
02
Drugs
minocycline
03
Conditions
schizophreniaschizoaffective disorderpsychotic disorder
Beyond the preview
Go deeper on NCT00916461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916461.